Alzheimer’s Disease :: Denial, Stigma Delaying Alzheimer’s Diagnoses
Most diagnoses of Alzheimer’s disease are delayed until more than two years after the first symptoms appeared, according to a survey released Tuesday.
Treatment
Atkins Diet :: Atkins diet not nutritionally balanced
The high-protein Atkins diet has caused a “life-threatening complication” for a woman who strictly followed the diet, say US doctors.
Stroke :: Stroke-prevention drug underutilized in minorities
Despite its proven efficacy in reducing the risk of stroke in patients with abnormal heart rhythm, the blood thinner warfarin is less commonly given to racial minorities, even though their risk of stroke is higher than that of whites, a new study shows.
Multiple Sclerosis :: Protein Test Could Spot Multiple Sclerosis Early
A spinal fluid protein may prove useful in identifying people with the earliest stages of multiple sclerosis (MS), say researchers at Johns Hopkins University in Baltimore.
Pregnancy :: Neoprene Suit Could Save Women’s Lives
A neoprene suit, similar to the bottom half of a diving wetsuit, can help save the lives of women suffering obstetrical bleeding during childbirth, a leading cause of death among women giving birth in developing nations.
Diabetes :: Gestational diabetes raises future diabetes risk
Gestational diabetes mellitus appears to increase the risk of developing diabetes later in life, Finnish investigators report in Diabetes Care.
Uterine Bleeding :: Hysterectomy costly way to treat uterine bleeding
Drug treatment is a significantly less costly means of treating abnormal uterine bleeding compared with hysterectomy, according to researchers. However, many patients may still eventually have to undergo hysterectomy.
Dermatitis :: Mystery Rash? Go for the Gold
All that itches is not gold, but the precious metal is among the leading causes of a skin condition called allergic contact dermatitis.
Back Pain :: Acupuncture appears effective for lower back pain
Acupuncture improves lower back pain, compared with no treatment, German researchers report. However, they found that a minimal intervention consisting of superficial needle placement at non-acupuncture points resulted in similar improvements.
Cancer :: First Head n Neck Cancer Treatment with Erbitux
The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.